tm
Seeing Is Believing
tm
Seeing Is Believing
Spark Therapeutics's activity chart (see below) currently has 117 price targets and 89 ratings on display.
Analysts average stock forecasts to be materialized ratio is 96.33% with an average time for these price targets to be met of 191.81 days.
Most recent stock forecast was given by GENA WANG from BARCLAYS on 25-Mar-2019. First documented stock forecast 24-Feb-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Mar-2019
$74
$-39.57 (-34.84%)
7 years 4 months 8 days ago
(25-Mar-2019)
6/7 (85.71%)
$-39.53 (-34.82%)
203
Buy Since 24-Feb-2015
$80
7 years 4 months 8 days ago
(25-Mar-2019)
5/5 (100%)
$23.99 (42.83%)
375
Buy Since 02-Aug-2017
$65
$-48.57 (-42.77%)
$65
7 years 5 months 6 days ago
(27-Feb-2019)
8/9 (88.89%)
$-48.4 (-42.68%)
179
Buy Since 12-Jul-2016
$72
7 years 5 months 7 days ago
(26-Feb-2019)
6/6 (100%)
$16.24 (29.12%)
280
Buy Since 13-Feb-2018
$114
$0.43 (0.38%)
$62
7 years 5 months 8 days ago
(25-Feb-2019)
4/4 (100%)
$0.52 (0.46%)
103
What is ONCE (Spark Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ONCE (Spark Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ONCE (Spark Therapeutics)?
Which analyst is the currently most bullish on ONCE (Spark Therapeutics)?
Which analyst is the currently most reserved on ONCE (Spark Therapeutics)?
